Single Technologies AB raises money for acceleration of DNA sequencing platform
Single Technologies aims to deliver a paradigm shift in biomolecular analysis with Theta platform
Single Technologies aims to deliver a paradigm shift in biomolecular analysis with Theta platform
Collaboration aims to develop the next-generation of engineered CHO cell lines and improve production of biotherapeutics
Waters enables core product portfolio with next-generation automation technology
Web-based platform provides access to one of the first ever cloud laboratory to integrate automated biology and chemistry research capabilities
This enhanced partnership promises to deliver end-to-end genomic solutions for plant research and development
This collaboration promises to develop stem cell therapies for life-threatening diseases
Major learned societies initiate two-year strategic alliance
This technology was showcased at the 2019 ASH Annual Meeting
Joint venture to develop next generation cell and gene therapies incorporating Affimer proteins
The molecule points the way toward treating viruses that cross from animals to humans
License agreement expands the rights to use and sell CRISPR/Cas9 reagents and tools
The tests will specifically adjust for isatuximab-induced interference in complete response assessment of multiple myeloma patients
Commercial U.S. launch of this novel diagnostic tool to diagnose lower respiratory tract infections is expected in the first quarter of 2020
Partnership will center on Prescient Medicine's novel genetic testing technology designed to objectively assess an individual's risk of opioid addiction
Scientists aim to gain new insights into natural cell activity, accelerating drug development
Enhertu targets the changes in HER2 that help the cancer grow, divide and spread